ストックスクリーナーアプリを入手
219.94
1.20%
-2.68
アフターアワーズ：
219.94
Resmed Inc (RMD) 最新ニュース
Jim Cramer On ResMed Inc. (RMD) – “I’m With Mick! ResMed’s Doing Quite Well” - Insider Monkey
ResMed Inc. (NYSE:RMD) is a favorite amongst institutional investors who own 72% - Simply Wall St
Solid sales from ASX healthcare leader - Morningstar.com.au
Is ResMed Stock Outperforming the Dow? - Nasdaq
ResMed initiated with an Overweight at Morgan Stanley - Yahoo Finance
Is ResMed Stock Outperforming The Dow? - Barchart
Resmed Says CPAP Therapy Reduces Risk Of Death By 37% In Sleep Apnea Patients - Nasdaq
Resmed’s Brand Evolution - Sleep Review
Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Yahoo Finance
Why Breville, Flight Centre, Orica, and ResMed shares are dropping today - MSN
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare And Medtronic - Barchart
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare and Medtronic - Yahoo Finance
Why APA, Aurelia Metals, Magnetic Resources, and ResMed shares are rising today - MSN
ResMed’s chief commercial officer sells $2.33 million in stock By Investing.com - Investing.com Australia
Should you buy this top ASX share in the dip? - MSN
Resmed to Consolidate Portfolio into One Brand; Shares Fall 5% -March 12, 2025 at 12:33 am EDT - Marketscreener.com
ResMed CFO Executes Stock Sale Under Rule 10b5-1 Plan - TipRanks
ResMed CFO Brett Sandercock sells $230,360 in company stock By Investing.com - Investing.com South Africa
ResMed CFO Brett Sandercock sells $230,360 in company stock - Investing.com India
Resmed Chief Commercial Officer Offloads $2.3 Million Worth of Shares -March 11, 2025 at 06:27 pm EDT - Marketscreener.com
Resmed Inc Announces Proposed Sale of Securities - TipRanks
ResMed Inc. CEO Reports Stock Transactions Under Rule 10b5-1 Plan - TipRanks
ResMed’s chief commercial officer sells $2.33 million in stock - Investing.com
Resmed unveils unified brand to streamline services - Mass Device
ResMed CEO Michael J. Farrell sells $1.84 million in stock - Investing.com India
Resmed Unveils Unified Brand To Lead The Global Sleep And Health Technology Revolution - Marketscreener.com
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution - The Korea Bizwire
Resmed Consolidating Brands, Product Lines Under Single Name -March 11, 2025 at 09:25 am EDT - Marketscreener.com
Resmed Unveils Comprehensive Brand Evolution to Enhance Global Sleep and Breathing Health Engagement - Nasdaq
Respiratory Inhalers Market to Witness Remarkable Growth with ResMed Inc., Fisher & Paykel Healthcare, Medtronic - openPR
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) - Yahoo Finance
ResMed Shows Market Leadership With Jump To 81 RS Rating - Investor's Business Daily
Jones Financial Companies Lllp Grows Stock Holdings in ResMed Inc. (NYSE:RMD) - Defense World
Brokers rate these 2 ASX growth stocks as top buys - MSN
ResMed Inc Officer Plans Sale of Common Shares - TipRanks
ResMed Among Top Stocks For Recent And Long-Term Profit Growth - Investor's Business Daily
ResMed Insiders Sold US$12m Of Shares Suggesting Hesitancy - Simply Wall St
ResMed (NYSE:RMD) Cut to “Hold” at StockNews.com - Defense World
Citi slaps buy rating on ResMed shares - MSN
Is it Worth Adding ResMed Stock to Your Portfolio Now? - MSN
ResMed (NYSE:RMD) Raised to “Buy” at Citigroup - Defense World
Stifel Nicolaus Issues Pessimistic Forecast for ResMed (NYSE:RMD) Stock Price - Defense World
Europe Sleep Apnea Devices Analysis Report 2025: Market Set - GlobeNewswire
Europe Sleep Apnea Devices Analysis Report 2025: Market Set for Notable Growth, Reaching $3.77 Billion by 2033 with Natus Medical, ResMed, and Koninklijke Philips Leading - Yahoo Finance
0.15%
1.06%
大文字化:
|
ボリューム (24 時間):